Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
221 Leser
Artikel bewerten:
(0)

Increasing Organizational Effectiveness in Pharmaceutical Industry Through Innovative Internal Communication

CHAPEL HILL, N.C., Feb. 20, 2012 /PRNewswire/ --As the technological frontier is being driven at an unprecedented rate in today's society, pharmaceutical and medical device companies are being forced to reinvent how to successfully communicate internally. In order to maintain communicational effectiveness, biopharma leaders are beginning to explore different forms and frequencies of internal communication, and identify the most preferred and effective channels.

Over 90% of respondents utilize emails to effectively communicate with colleagues. However, other forms of communication are also increasing in importance. Pharmaceutical respondents depend much more heavily on blog postings than weekly newsletters, podcasts, and most surprisingly voicemail, according to primary research on "Internal Communication Success: Best Practices within the Pharmaceutical and Medical Industries to Ensure Organizational Effectiveness" conducted by Best Practices, LLC. Overall, companies rated emails and the intranet as more effective ways to share industry information internally than face to face meetings.

Download a complimentary white paper at http://www3.best-in-class.com/rr1147.htm that includes selected best practices drawn from extensive primary research with 37 executives from over 30 leading pharma companies.

Research objectives included:

  • Identify types of internal communication mostly used by executives
  • Identify preferred medium for internal communication
  • Measure internal communication effectiveness

The full 45-page report contains over 200 benchmark metrics and highlights the preferred channels and tools for communication. In addition, the research delves into the best communication frequencies and approaches for internal communications.

Specifically, this primary research identifies the most effective and preferred communication strategies for reaching internal executives. The study also seeks to help pharmaceutical and medical device companies compare their current internal communication strategies with that of benchmark class companies.

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.

The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.